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Massive allograft can be a useful option in revision total joint arthroplasty for treatment of signiﬁcant bone
loss. In rare cases, revision hip and knee arthroplasty procedures can be performed simultaneously using
massive allograft-prosthetic composites. We present an 18 year follow up of a patient who received a
simultaneous revisionhipandknee total femoral allograft anddiscuss recent literatureas it relates to this case.
Copyright © 2015 Published by Elsevier Inc. on behalf of American Association of Hip and Knee Surgeons.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Revision total joint arthroplasty has many variables to consider
when surgical planning begins. One of the most important of those
is the amount of bone available to facilitate the revision. In the
event of excessive bone loss, the options become even more
limited. When the joints being revised involve the ipsilateral total
hip and total knee arthroplasty simultaneously, the options include
resection arthroplasty, megaprosthesis, large structural allograft, or
amputation. In order to preserve as much function as possible,
resection arthroplasty and amputation are avoided at all costs.closed potential or pertinent
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A 79-year-old female with severe rheumatoid arthritis under-
went right total femoral allograft with simultaneous THA revision
and TKA revision in 1996. The massive allograft was used for
treatment of a distal femoral periprosthetic fracturewith persistent
non-union despite several surgical interventions attempting to
achieve bony union (Fig. 1). A femoral allograft was selected pre-
operatively based on templating the patient's host bone for size
and components likely to be used for procedure. A lateral approach
was used as well as a trochanteric slide to expose the length of the
femur. An oscillating saw was used to split the lateral cortex of the
femur and the previous components were taken out proximally and
distally, while verifying the acetabulum and tibial components
were still stable. Using standard instrumentation, a long-stemmed
femoral hip implant and semi-constrained knee implant were
cemented simultaneously to create a single uniform cement
mantle. The allograft was then placed into the host bone shell that
remained hinged medially, and bone graft was placed at the
interface to enhance union. Multiple cerclage wires and cable grip
greater trochanter attachment were used to ﬁnalize ﬁxation [1].
Two weeks post-op, she did have a dislocation that was closed
reduced and treated with a single leg spica cast for a period of sixn of Hip and Knee Surgeons. This is an open access article under the CC BY-NC-ND
Figure 1. AP radiograph of right hip (a) and knee (b) after initial hip revision and internal ﬁxation of the distal femur. AP (c) and lateral (d) radiographs of right knee after per-
iprosthetic fracture following conversion to total knee replacement.
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level of function, ambulating with a cane, WBAT and doing well. At
three years she was seen, also doing well, with a Harris Hip Score of
75 at that time. Ofﬁce notes were reviewed at 8 and 10 years, where
she stated no pain in the right hip and that she was doing well, with
no additional procedures to the right hip noted during the interval.
The patient continued to do well and was very functional for over 17
years post-operatively (Fig. 2). This patient and method were pre-
viously described by Urch and Moskal [1].
After nearly two decades with a well functioning prosthesis the
patient was diagnosed with acute methicillin-resistant Staphylo-
coccus aureus (MRSA) sepsis and bacteremia of unknown origin.
She was hospitalized for several weeks in another facility and was
in the ICU secondary to concern for sepsis related cardiac events.
She was found to have an infected pacemaker that was subse-
quently removed. Shewas treated with IV antibiotics and recovered
sufﬁciently to be discharged from the hospital. Two weeks after
discharge she developed right hip and knee pain. Clinical evalua-
tion showed a right knee effusion and an aspiration revealed 15,655
WBCs with 83% neutrophils, and the knee aspiration culture
showed 2þ MRSA. Given her TKA infection and hip pain with
probable infection of her entire allograft, removal of her entire
component was recommended. Because of her advanced age and
multiple medical comorbidities, hip disarticulation was recom-
mended, as it was not felt she could safely tolerate staged revision
with antibiotic spacer. Additionally, debridement and chronic
antibiotic suppressionwere also discussed, however due to the size
of her allograft, complete debridement would be difﬁcult with
signiﬁcant risk of recurrence.
Intra-operative ﬁndings noted full incorporation of her allograft
and continued mechanical stability. A tract was identiﬁed at the
time of surgery between areas of the allograft and the outer host
bone that was closed and cabled around the allograft during theinitial procedure (Fig. 3). Purulent material tracked from the TKA
components proximally to the THA components and prosthetic
infection of the hip was conﬁrmed. The patient has since healed her
disarticulation incision sitewell with no signs of recurrent infection
and has been able to transfer herself from bed to wheelchair
without assistance (Fig. 4).
Discussion
The surgical options for managing patients with excessive bone
loss have evolved over the past century. These options have also
been greatly impacted by the advent of THA and TKA. The ﬁrst
review of massive bone allografts dates back to the early 1900s by
Lexer, while the ﬁrst femur allograft procedure was described in
1965 by Buchman [2,3]. Before that, the only options were ampu-
tation or hip disarticulation. Resection arthroplasty became a viable
option when the need to retain the limb or salvage an extremity
was greater than the need for an amputation, or when there was
concern that a patient could not tolerate a more extensive proce-
dure. As treatment protocols evolved and the ability to replace bone
loss became more practical, the pendulum swung toward limb
salvage in the majority of cases. The ability to retain mobility and
range of motion using metal arthroplasty for degenerative joint
disease and other pathology further advanced retention of a func-
tional limb to aid in mobility. This case update looks at selected
literature since our patient was ﬁrst presented in Journal of
Arthroplasty in 1998.
Patients in need of these procedures usually fall into two sub-
sets: bone loss due to tumor/malignancy or bone loss associated
with total joint arthroplasty. In 2010, Ruggieri reviewed results of
patients who received either a megaprosthesis or an allograft for a
tumor diagnosis. The review comprised of 23 patients over
19 years. Six patients continued to be disease free, 13 died from
Figure 2. AP pelvis (a) and right knee (b) radiograph 17 years after right total femoral allograft. Lateral right femur (c) and right knee (d) radiograph 17 years after right total femoral
allograft.
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dence of disease after remission, one was alive with disease in
stable condition, and two were lost to follow-up. Five out of
21 (24%) had complications requiring revision surgery, 2 infections
and 3 mechanical failures. Importantly, it should be noted all pa-
tients in this review underwent hemiarthroplasty of their hip
without placement of an acetabular cup [4].
Amanatullah et al. in JOA in 2014 (Manuscript accepted)
reviewed 20 non-tumor related allografts. Overall infection rate
was 35%, average follow-up was 73 months, overall instability was
25%, and an HHS score increase of 35 points on average in func-
tional scoring between pre-op and post-op was noted. Additionally,
as opposed to the Ruggieri review, no hemiarthroplasties were
preformed in this cohort with all implants including acetabular
replacement [4,5].
Another orthopedic oncology based review from Puri et al. in
India reported on 8 patients that received a total femoral prosthesis
at an average of 32 years old. One infection required hardware
removal, but 7 of 8 still had functional use at 5 years. A Kaplan
Meier survival score of 88% of the prosthesis persisted at the time of
publication. One other element of interest from this publication, the
implant that was used was locally manufactured and cost only$2000. It was noted that similar hardware used internationally
would average a cost more than 9 times this amount, or $18,000.
This could prove to be ﬁscally signiﬁcant in a time of constant cost
analysis and call for savings [6].
Mankin reviewed 15 patients over a 23-year period; the ma-
jority of which had procedures performed for tumor related pro-
cesses. Ten of the 15 patients had procedures with TKA and THA
allograft composites implanted similar to our case study, whereas
the other 5 underwent replacement with megaprosthesis. Seven
patients were still living with well functioning prostheses, but eight
patients died during that time. Of note, the two non-oncologic
patients in this group, one was a Paget's disease patient and one
with osteonecrosis, were alive at follow up, showing the potential
effectiveness of this procedure on a non-oncology condition.
Mankin showed that there were no functional differences between
the 10 allografts and the 5 megaprosthesis. There were no dislo-
cations in the group and also only one irrigation and debridement
washout with implant retention for treatment of infection. Tren-
delenburg gait tended to be higher in patients with all metal
devices versus patients with allografts prosthetic composites [7].
Muscolo et al. reported on 6 cases of femoral allograft followed
for 22e36 years. This review included three intercalary grafts, one
Figure 3. Intra-operative photographs (a and b) and AP radiograph of composite allograft (c). The surgical tool in the photographs is pointing to the sinus tract between the allograft
and host bone noted during hip disarticulation.
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entire femoral allograft had low functional scores due to walking
limitations, but pain was not a limiting factor for this patient. Four
allografts did have fractures, and with 3 going on to healing and
retained a good functional status post-intervention. Otherwise,
MTSS functional scores averaged 82% and this study showed po-
tential longevity up to 36 years in these patients [8].
Jones et al. reviewed 54 total femoral replacements from
3 institutional databases with a very thorough functional scoreanalysis. The analysis included 41 ﬁxed bearing knees, 13 rotating
hinge knees, 37 hip hemiarthroplasties, and 17 total hip arthro-
plasties. The functional scores from the 54 TFRs were compared to
patients with proximal femoral replacements (n ¼ 31) and distal
femoral replacements (n ¼ 85). Toronto Extremity Salvage Scores
were utilized for functional analysis. There was no signiﬁcant dif-
ference in rotating platform versus ﬁxed bearing TKA or in hemi-
arthroplasty versus total hip replacement patients. The functional
scores of the TFRs were signiﬁcantly less than those of the PFRs and
Figure 4. Post-operative AP radiograph following right hip disarticulation.
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5 hip dislocations, 4 of which were noted to be due to abductor
deﬁciency on surgical re-evaluation [9].
Haddad et al. performed a review of proximal femur allografts,
but not entire femoral allografts, and raised several good points
that bear mentioning. There are noted advantages and disadvan-
tages for using allografts in these patients. The ability of allografts
to incorporate with host bone and allow for soft tissue attachment
may enhance stability in these patients, improving function and
satisfaction. The disadvantages also have to be considered, how-
ever, which include the potential for disease transmission, immune
response, graft resorption, and the length of time required for graft-
host union. Unrestricted weight bearing may not be allowed for
3e6 months depending on graft incorporation. If weight bearing is
attempted early, the risk of loosening increases if in-growth has not
been achieved. Additionally, there may be a need for bracing post-
op to allow soft tissue healing and to enhance stability. Haddad
et al. also noted infection rates in proximal femoral allografts alone
can be as high as 4%e13% [10].
Summary
In conclusion, despite the advancement of engineering and
technology, the total femoral allograft remains a valid treatmentoption in the patients with ipsilateral hip and knee bone loss who
require revision. The longevity of these constructs can last over 30
years in the medically appropriate candidate [8]. There is some
evidence showing this method, due to soft tissue healing potential,
may enhance abductor functioning and alleviate limp in some pa-
tients, as compared to some megaprosthesis designs that do not
facilitate greater trochanter capture [7]. Infection rate is always a
concern, with reported rates between 6% and 35% [4e8]. Our pa-
tient had a history of severe rheumatoid arthritis, which may have
lead to her long prosthetic survival with low functional demands,
however it may have contributed to her infection with immune
system compromise allowing for seeding of her prosthesis during
systemic bacteremia. Her risk also was substantially elevated sec-
ondary to the number of procedures she had on her right lower
extremity, hip and knee, before the allograft was placed. Four hip
procedures (primary THA plus 3 revisions) and three knee pro-
cedures (ORIF times two and then primary TKA) were noted before
the allograft was placed and would have increased her chances of
acquiring infection during every intervention. However, the func-
tional beneﬁts she achieved over the 17 years since her procedure,
combined with the literature review of similar procedures out-
comes, allow this treatment to be considered an acceptable alter-
native to reconstruction with total femur replacement.References
[1] Urch SE, Moskal JT. Simultaneous ipsilateral revision total hip arthroplasty and
revision total knee arthroplasty with entire femoral allograft: case report.
J Arthroplasty 1998;13:833.
[2] Lexer E. Substitution of whole or half joints from freshly amputated extrem-
ities by free plastic operations. Surg Gynecol Obstet 1908;6:601.
[3] Buchman J. Total femur and knee joint replacement with a vitallium endo-
prosthesis. Bull Hosp Joint Dis 1965;26:21.
[4] Ruggieri P, Bosco G, Pala E, Errani C, Mercuri M. Local recurrence, survival and
function after total femur resection and megaprosthesis reconstruction for
bone sarcomas. Clin Orthop Relat Res 2010;468:2860.
[5] Amanatullah DF, Trousdale RT, Hanssen AD, Lewallen DG, Taunton MJ.
Non-oncologic total femoral arthroplasty: retrospective review. J Arthroplasty
2014;29(10):2013.
[6] Puri A, Gulia A, Chan WH. Functional and oncologic outcomes after excision of
the total femur in primary bone tumors: results with a low cost total femur
prosthesis. Indian J Orthop 2012 JuleAug;46:470.
[7] Mankin HJ, Hornicek FJ, Harris M. Total femur replacement procedures in
tumor treatment. Clin Orthop Relat Res 2005;438:60.
[8] Muscolo DL, Petracchi LJ, Ayerza MA, Calabrese ME. Massive femoral allografts
followed for 22 to 36 years. Report of six cases. J Bone Joint Surg Br 1992;74-
B(6):887.
[9] Jones J, Grifﬁn AM, Coonoor RC, et al. Patient-oriented functional results of
total femoral endoprosthetic reconstruction following oncologic resection.
J Surg Oncol 2011 Nov 1;104(6):561.
[10] Haddad FS, Garbuz DS, Masri BA, et al. Femoral bone loss in patients managed
with revision hip replacement: results of circumferential allograft replace-
ment. J Bone Joint Surg 1999;81-A(3):420.
